Dr Terri Cooper is a retired Principal of Deloitte’s US consulting practice, is a 35-year life sciences-healthcare veteran.
She led Deloitte’s global healthcare sector and built the firm’s Life Sciences R&D practice. From 2017, Terri led Deloitte’s US Diversity, Equality and Inclusion (DEI) programme and from 2020 was Vice-Chair of the firm’s External DEI practice. As a recognised life sciences healthcare expert, Terri has worked across sectors globally in both public and private domains with complex industry, business, technology, DEI, brand-building, and regulatory imperatives.
Terri is the Board Chair for Verso Biosense, the Vice Chair of the Board for Classical Theatre of Harlem, and also sits on the advisory boards of the USTA Foundation and EnrichedHQ. She holds a bachelor’s degree in chemistry and pharmacology from the University of Nottingham and a PhD in Pharmacology from the University of London.Back to our trustees